These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Relationship between the CHA2DS2-VASc score and atrial fibrillation in patients hospitalised due to heart failure.
    Author: Kuczaj A, Nowalany-Kozielska E, Skrzypek M, Opolski G, Ociessa A, Jankowska E, Ponikowski P, Wożakowska-Kapłon B, Mirek-Brynarska E, Drożdż J.
    Journal: Kardiol Pol; 2019; 77(3):380-385. PubMed ID: 30835325.
    Abstract:
    BACKGROUND: Heart failure (HF) has become an epidemic. A similar situation is also observed for atrial fibrillation (AF). The CHA2DS2-VASc score is one of the most useful tools for thromboembolic risk assessment. AIM: The aim of the study was to assess the prevalence of AF in patients with decompensated HF, who were divided into subgroups according to the CHA2DS2-VASc score. METHODS: We analysed the prevalence of AF in a group of 1108 patients (327 women) hospitalised due to HF decompensa- tion in medical centres of different referral levels. Twenty-one patients refused to participate in the registry. The data were collected from Polish centres included in the European Society of Cardiology Heart Failure Long-Term Registry. The recruit- ment period was from 2011 to 2014. The data were analysed retrospectively. Patients were divided into groups according to the CHA2DS2-VASC score. RESULTS: The study sample was characterised by a high occurrence of AF (44.3%), with the highest prevalence in patients with a CHA2DS2-VASC score ≥ 6 (61.3%, p = 0.01). CONCLUSIONS: The CHA2DS2-VASc score may be a useful tool for detecting patients with HF characterised by the highest risk of AF.
    [Abstract] [Full Text] [Related] [New Search]